Free Trial

Tourmaline Bio (TRML) Insider Trading & Ownership

Tourmaline Bio logo
$20.65 +0.31 (+1.52%)
(As of 12/20/2024 05:31 PM ET)

Tourmaline Bio (NASDAQ:TRML) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.02%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$3.32 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get TRML Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tourmaline Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TRML Insider Buying and Selling by Quarter

Tourmaline Bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/16/2024Sandeep Chidambar KulkarniCEOBuy5,221$13.79$71,997.59  
1/29/2024Mark McdadeDirectorBuy100,000$32.50$3,250,000.00  
(Data available from 1/1/2013 forward)

TRML Insider Trading Activity - Frequently Asked Questions

The list of insiders at Tourmaline Bio includes Aaron Kantoff, Caley Castelein, Mark Mcdade, Parvinder Thiara, and Sandeep Chidambar Kulkarni. Learn more on insiders at TRML.

11.02% of Tourmaline Bio stock is owned by insiders. Learn more on TRML's insider holdings.

The following insiders have purchased TRML shares in the last 24 months: Aaron Kantoff ($88,950.00), Caley Castelein ($229,890.00), Mark Mcdade ($3,250,000.00), Parvinder Thiara ($17,310.00), and Sandeep Chidambar Kulkarni ($250,869.59).

Insiders have purchased a total of 143,171 TRML shares in the last 24 months for a total of $3,837,019.59 bought.

Tourmaline Bio Key Executives

  • Dr. Sandeep C. Kulkarni M.D. (Age 42)
    Co-Founder, CEO & Director
    Compensation: $753.02k
  • Dr. Yung H. Chyung M.D. (Age 47)
    Chief Medical Officer
    Compensation: $624.63k
  • Dr. Kevin B. Johnson M.B.A. (Age 60)
    Ph.D., Chief Regulatory Officer
    Compensation: $555.84k
  • Mr. Ryan Robinson CPA (Age 36)
    VP of Finance, Controller & Interim CFO
  • Dr. Susan Dana Jones Ph.D. (Age 64)
    Chief Technology Officer
  • Mr. W. Bradford Middlekauff J.D. (Age 62)
    Chief Business Officer, General Counsel & Corporate Secretary
  • Ms. Kimberly Piorkowski
    Vice President of People, Culture and Compliance
  • Mr. Ryan Iarrobino
    SVP of Product Development
  • Ms. Dora Rau
    Senior Vice President & Head of Quality
  • Mr. Gerhard Hagn Pharm.D.
    Senior VP and Head of Commercial & Business Development


This page (NASDAQ:TRML) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners